Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 12, 2015, Pages 2152-2158

  Araki, Shin Ichi ^a   Haneda, Masakazu ^b   Koya, Daisuke ^c   Kondo, Keiko ^a   Tanaka, Sachiko ^a   Arima, Hisatomi ^a   Kume, Shinji ^a   Nakazawa, Jun ^a   Chin Kanasaki, Masami ^a   Ugi, Satoshi ^a   Kawai, Hiromichi ^a   Araki, Hisazumi ^a   Uzu, Takashi ^a   Maegawa, Hiroshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; POTASSIUM; SODIUM;

ADULT; ANGINA PECTORIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEMODIALYSIS; HUMAN; HYPERTENSION; JAPANESE (PEOPLE); KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; POTASSIUM EXCRETION; POTASSIUM URINE LEVEL; SODIUM URINE LEVEL; URINALYSIS; AGED; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE COURSE; FOLLOW UP; INCIDENCE; JAPAN; KAPLAN MEIER METHOD; KIDNEY; MIDDLE AGED; NATRIURESIS; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTECTION; RENAL INSUFFICIENCY; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; URINARY EXCRETION; URINE;

AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURESIS; POTASSIUM; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RENAL ELIMINATION; RENAL INSUFFICIENCY; RISK FACTORS; SODIUM; TIME FACTORS;

EID: 84952707887     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00980115     Document Type: Article

References (29)

1. American Diabetes Association: Standards of medical care in diabetes–2014. Diabetes Care 37 1: S14–S80, 2014.
2. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention onmortality in type 2 diabetes. NEngl J Med 358: 580–591, 2008.
3. Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, Isono M, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A: Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes. Diabetes 56: 1727–1730, 2007.
4. The Japan Diabetes Society: Treatment Guide for Diabetes 2012-2013. Available at: http://www.jds.or.jp/modules/en/index.php?content_id=1. Accessed August 28, 2015.
5. Dodson PM, Beevers M, Hallworth R, Weberley MJ, Fletcher RF, Taylor KG: Sodium restriction and blood pressure in hypertensive type II diabetics: Randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 298: 227–230, 1989.
6. Suckling RJ, He FJ, Macgregor GA: Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev (12): CD006763, 2010.
7. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH; FinnDiane StudyGroup: The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34: 861–866, 2011.
8. Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G: Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34: 703–709, 2011.
9. StolarzSkrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovsky´ J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA; European Project on Genes in Hypertension (EPOGH) Investigators: Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305: 1777–1785, 2011.
10. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP: Effect of increased potassium intake on cardiovascular risk factors and disease: Systematic review and meta-analyses. BMJ 346: 1378, 2013.
11. Hidaka H, Terada M, Maegawa H, Kojima H, Koya D, Nishio Y, Haneda M, Yasuda H, Kashiwagi A, Kikkawa R: Evaluation of a new care system provided to diabetic patients in the outpatient clinic. Intern Med 39: 783–787, 2000.
12. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D: Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria. Diabetes Care 29: 864–868, 2006.
13. Araki S, Haneda M, Koya D, Sugaya T, Isshiki K, Kume S, Kashiwagi A, Uzu T, Maegawa H: Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care 36: 1248–1253, 2013.
14. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K; Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 1: 212–228, 2010.
15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982–992, 2009.
16. Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK; Trials of Hypertension Prevention Collaborative Research Group: Joint effects of sodium and potassium intake on subsequent cardiovascular disease: The Trials of Hypertension Prevention follow-up study. Arch Intern Med 169: 32–40, 2009.
17. Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB: Sodium and potassium intake and mortality among US adults: Prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 171: 1183–1191, 2011.
18. O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE: Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306: 2229–2238, 2011.
19. O’Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, Rosengren A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Yusoff K, Iqbal R, Ilow R, Mohammadifard N, Gulec S, Yusufali AH, Kruger L, Yusuf R, Chifamba J, Kabali C, Dagenais G, Lear SA, Teo K, Yusuf S; PURE Investigators: Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 371: 612–623, 2014.
20. Smyth A, Dunkler D, Gao P, Teo KK, Yusuf S, O’Donnell MJ, Mann JF, Clase CM;ONTARGETand TRANSCEND investigators: The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int 86: 1205–1212, 2014.
21. World HealthOrganization: Guideline: SodiumIntake for Adults and Children, Geneva, Switzerland, 2012.
22. Mente A, O’Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, Morrison H, Li W, Wang X, Di C, Mony P, Devanath A, Rosengren A, Oguz A, Zatonska K, Yusufali AH, Lopez-Jaramillo P, Avezum A, Ismail N, Lanas F, Puoane T, Diaz R, Kelishadi R, Iqbal R, Yusuf R, Chifamba J, Khatib R, Teo K, Yusuf S; PURE Investigators: Association of urinary sodiumand potassium excretion with blood pressure. NEngl J Med 371: 601–611, 2014.
23. Hedayati SS, Minhajuddin AT, Ijaz A, Moe OW, Elsayed EF, Reilly RF, Huang CL: Association of urinary sodium/potassium ratio with blood pressure: Sex and racial differences. Clin J Am Soc Nephrol 7: 315–322, 2012.
24. He FJ, MacGregor GA: Beneficial effects of potassium on human health. Physiol Plant 133: 725–735, 2008.
25. Ghanim H, Mohanty P, Pathak R, Chaudhuri A, Sia CL, Dandona P: Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care 30: 1406–1411, 2007.
26. Buscemi S, Rosafio G, Arcoleo G, Mattina A, Canino B, Montana M, Verga S, Rini G: Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk. Am J Clin Nutr 95: 1089–1095, 2012.
27. Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators: Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med 173: 1682–1692, 2013.
28. Ying WZ, Aaron K, Wang PX, Sanders PW: Potassium inhibits dietary salt-induced transforming growth factor-beta production. Hypertension 54: 1159–1163, 2009.
29. Intersalt Cooperative Research Group: Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 297: 319–328, 1988.